eli lilly tirzepatide fda approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - FDA confirms tirzepatide shortage is

This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2)

GLP-1s, appetite & nutrition GLP-1 receptor agonists work by slowing digestion and reducing appetite, which leads to lower overall food intake

Inactive ingredients like sodium chloride, sodium phosphate dibasic heptahydrate, hydrochloric acid, and water for injection help maintain the solutions pH, stability, and comfort during injection

Supporting this enzyme helps promote healthy metabolism

Is it not

Individual tolerability varies from person to person, which is part of why provider guidance matters